ArticleJapanese journal of clinical oncology2025

Practical guidance on the clinical management of ocular adverse events associated with belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Recommendations from a Japanese expert panel.

Kazutaka Sunami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.